The Hydrophilic Wire Guide segmentation by application distinguishes four primary clinical domains: coronary interventions, peripheral vascular procedures, neurovascular applications, and structural heart therapies. Coronary interventions dominate the market, accounting for roughly 35% of total demand, driven by high procedural volumes and the need for precise navigation in complex arterial anatomies. Peripheral vascular procedures contribute about 30%, reflecting expanding use in peripheral artery disease management where long, tortuous pathways benefit from the low-friction properties of hydrophilic coatings. Neurovascular applications, representing 20% of the market, are propelled by increasing adoption in intracranial aneurysm and stroke interventions, where guidewire flexibility and trackability are critical. Structural heart therapies, comprising the remaining 15%, are emerging as a niche segment, supporting transcatheter valve replacements and closure devices that require meticulous device delivery. Collectively, these application categories shape the overall market size by aligning product development with procedural complexity and volume trends.